Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials
Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials
Prostate Cancer and Prostatic Diseases advance online publication, November 11 2014.
doi:10.1038/pcan.2014.44
Authors: D L Suzman, X C Zhou, M L Zahurak, J Lin & E S Antonarakis
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: D L SuzmanX C ZhouM L ZahurakJ LinE S Antonarakis Source Type: research